Ovarian Cancer Radiosensitivity: What Have We Understood So Far?

被引:6
|
作者
Barcellini, Amelia [1 ,2 ]
Charalampopoulou, Alexandra [3 ]
De Cecco, Loris [4 ]
Fodor, Andrei [5 ]
Rabaiotti, Emanuela [6 ]
Candotti, Giorgio [6 ]
Secondino, Simona [7 ]
Facoetti, Angelica [3 ]
Locati, Laura Deborah [2 ,8 ]
Pignata, Sandro [9 ]
Orlandi, Ester [1 ]
Mangili, Giorgia [6 ]
机构
[1] Natl Ctr Oncol Hadrontherapy CNAO, Clin Dept, Radiat Oncol Unit, I-27100 Pavia, Italy
[2] Univ Pavia, Dept Internal Med & Med Therapy, I-27100 Pavia, Italy
[3] Natl Ctr Oncol Hadrontherapy CNAO, Res & Dev Dept, Radiobiol Unit, I-27100 Pavia, Italy
[4] Fdn IRCCS Ist Nazl Tumori, Dept Res, Mol Mech Unit, I-20133 Milan, Italy
[5] IRCCS San Raffaele Sci Inst, Dept Radiat Oncol, I-20132 Milan, Italy
[6] IRCCS San Raffaele Sci Inst, Unit Gynaecol & Obstet, I-20132 Milan, Italy
[7] IRCCS Policlin San Matteo, Med Oncol Unit, I-27100 Pavia, Italy
[8] Maugeri Clin Res Inst IRCCS, Translat Oncol Unit, I-27100 Pavia, Italy
[9] IRCCS Fdn G Pascale Napoli, Ist Nazl Tumori, Dept Urol & Gynecol, I-80131 Naples, Italy
来源
LIFE-BASEL | 2023年 / 13卷 / 01期
关键词
ovarian cancer; radiobiology; radioresistance; radiosensitivity; radiation; EXHIBITING GENETIC ALTERATIONS; CARCINOMA-CELL-LINES; RADIATION-THERAPY; RADIOTHERAPY; SENSITIVITY; IMMUNOTHERAPY; COMBINATION; EXPRESSION; IMMUNITY; MODEL;
D O I
10.3390/life13010006
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Radiotherapy has been increasingly considered as an active treatment to combine with other approaches (i.e., surgery, chemotherapy, and novel target-based drugs) in ovarian cancers to palliate symptoms and/or to prolong chemotherapy-free intervals. This narrative review aimed to summarize the current knowledge of the radiosensitivity/radioresistance of ovarian cancer which remains the most lethal gynecological cancer worldwide. Indeed, considering the high rate of recurrence in and out of the radiotherapy fields, in the era of patient-tailored oncology, elucidating the mechanisms of radiosensitivity and identifying potential radioresistance biomarkers could be crucial in guiding clinical decision-making.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Immunotherapy in colorectal cancer: What have we learned so far?
    Sanchez-Castanon, Maria
    Er, Tze-Kiong
    Bujanda, Luis
    Herreros-Villanueva, Marta
    CLINICA CHIMICA ACTA, 2016, 460 : 78 - 87
  • [2] PAX8 as a Potential Target for Ovarian Cancer: What We Know so Far
    Di Palma, Tina
    Zannini, Mariastella
    ONCOTARGETS AND THERAPY, 2022, 15 : 1273 - 1280
  • [3] Dent disease in Poland: what we have learned so far?
    Zaniew, Marcin
    Mizerska-Wasiak, Malgorzata
    Zaluska-Lesniewska, Iga
    Adamczyk, Piotr
    Kilis-Pstrusinska, Katarzyna
    Halinski, Adam
    Zawadzki, Jan
    Lipska-Zietkiewicz, Beata S.
    Pawlaczyk, Krzysztof
    Sikora, Przemyslaw
    Ludwig, Michael
    Szczepanska, Maria
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2017, 49 (11) : 2005 - 2017
  • [4] Business cycle accounting: What have we learned so far?
    Brinca, Pedro
    Costa Filho, Joao Ricardo
    Loria, Francesca
    JOURNAL OF ECONOMIC SURVEYS, 2024, 38 (04) : 1276 - 1316
  • [5] Brain tumor immunotherapy: what have we learned so far?
    Van Gool, Stefaan Willy
    FRONTIERS IN ONCOLOGY, 2015, 5
  • [6] RISK FACTORS FOR THYROID CANCER: WHAT DO WE KNOW SO FAR?
    Crncic, Tatjana Bogovic
    Tomas, Maja Ilic
    Girotto, Neva
    Ivankovic, Svjetlana Grbac
    ACTA CLINICA CROATICA, 2020, 59 : 66 - 72
  • [7] Classifying Information Systems Risks: What Have We Learned So Far?
    Wiesche, Manuel
    Keskinov, Hristo
    Schermann, Michael
    Krcmar, Helmut
    PROCEEDINGS OF THE 46TH ANNUAL HAWAII INTERNATIONAL CONFERENCE ON SYSTEM SCIENCES, 2013, : 5013 - 5022
  • [8] A view on dendritic cell immunotherapy in ovarian cancer: how far have we come?
    Coosemans, A.
    Baert, T.
    Vergote, I.
    FACTS VIEWS AND VISION IN OBGYN, 2015, 7 (01) : 73 - 78
  • [9] The desiccation tolerant secrets of Selaginella lepidophylla: What we have learned so far?
    Pampurova, Suzana
    Van Dijck, Patrick
    PLANT PHYSIOLOGY AND BIOCHEMISTRY, 2014, 80 : 285 - 290
  • [10] Improving oocyte quality in cows and heifers - What have we learned so far?
    Blondin, P.
    Vigneault, C.
    Nivet, A. L.
    Sirard, M. A.
    ANIMAL REPRODUCTION, 2012, 9 (03) : 281 - 289